Abstract:Testing for infection with SARS-CoV-2 is an important intervention in reducing onwards transmission of COVID-19, particularly when combined with the isolation and contact-tracing of positive cases. Many countries with the capacity to do so have made use of lab-processed Polymerase Chain Reaction (PCR) testing targeted at individuals with symptoms and the contacts of confirmed cases. Alternatively, Lateral Flow Tests (LFTs) are able to deliver a result quickly, without lab-processing and at a relatively low cost. Their adoption can support regular mass asymptomatic testing, allowing earlier detection of infection and isolation of infectious individuals. In this paper we extend and apply the agent-based epidemic modelling framework Covasim to explore the impact of regular asymptomatic testing on the peak and total number of infections in an emerging COVID-19 wave. We explore testing with LFTs at different frequency levels within a population with high levels of immunity and with background symptomatic PCR testing, case isolation and contact tracing for testing. The effectiveness of regular asymptomatic testing was compared with `lockdown' interventions seeking to reduce the number of non-household contacts across the whole population through measures such as mandating working from home and restrictions on gatherings. Since regular asymptomatic testing requires only those with a positive result to reduce contact, while lockdown measures require the whole population to reduce contact, any policy decision that seeks to trade off harms from infection against other harms will not automatically favour one over the other. Our results demonstrate that, where such a trade off is being made, at moderate rates of early exponential growth regular asymptomatic testing has the potential to achieve significant infection control without the wider harms associated with additional lockdown measures.

What problem does this paper attempt to address?

### The problems the paper attempts to solve This paper attempts to explore the role of regular asymptomatic testing in reducing the peak and total number of infections in emerging COVID - 19 epidemics. Specifically, the researchers used the agent - based epidemic modeling framework Covasim to simulate the impact of lateral flow tests (LFTs) at different frequencies in highly immune populations, combined with symptomatic PCR testing, case isolation, and contact - tracing strategies in the background. The study also compared the effectiveness of regular asymptomatic testing with "lockdown" measures to reduce infections by restricting non - household contacts. ### Main research questions 1. **Effect of regular LFT testing**: - How effective is regular LFT testing in reducing the total number of infections and the peak number of infections at different testing frequencies? - How effective is regular LFT testing at different testing and isolation adoption rates? 2. **Percentage reduction in non - household contacts**: - What percentage of non - household contacts needs to be reduced to achieve the same infection - reduction effect as regular asymptomatic testing? 3. **Impact of TTI strategy compliance on the number of infections**: - Isolation when symptoms appear; - Testing of symptomatic individuals; - Testing of contacts after identifying positive cases. 4. **Costs of different testing policies**: - For different testing policies, how many days are people required to be isolated at home and what is the required number of tests? 5. **Comparison between single LFD test and single PCR test**: - When symptomatic, what are the advantages of a single LFD test compared to a single PCR test? ### Method overview The researchers used the Covasim model, an agent - based model for simulating the transmission dynamics between individuals. Multiple intervention measures were considered in the model, including vaccination, isolation when symptoms appear, testing, and contact - tracing. By adjusting the model parameters, the researchers simulated the epidemic development under different testing frequencies and compliance levels and compared it with the "lockdown" measures to reduce non - household contacts. ### Results overview - **Effect of regular asymptomatic testing**: - A testing policy twice a week can reduce the total number of infections by 6.6% to 44.6% (depending on different contact patterns and growth rates) at 100% compliance. - A once - a - week testing policy can reduce the total number of infections by 3.9% to 32.9% at 100% compliance. - A testing policy every two days can reduce the total number of infections by 8.6% to 71.0% at 100% compliance. - **Percentage reduction in non - household contacts**: - The effect of regular asymptomatic testing is equivalent to reducing 25% to 45% of non - household contacts. - **Compliance of TTI strategy**: - Isolation when symptoms appear, testing of symptomatic individuals, and testing of contacts have a significant impact on the number of infections, and the higher the compliance, the better the effect. - **Costs of different testing policies**: - Regular asymptomatic testing will increase the number of days people are isolated, but the magnitude of the increase depends on the testing frequency and the epidemic growth rate. - **Comparison between single LFD test and single PCR test**: - The sensitivity and specificity of a single LFD test when symptomatic are comparable to those of a PCR test, and it is less costly and faster. ### Conclusion The study shows that regular asymptomatic testing can effectively control the spread of COVID - 19 without causing widespread social harm. Especially in the case of moderate growth rates, regular asymptomatic testing can significantly reduce the number of infections without the need for comprehensive lockdown measures. This provides policymakers with a new method to balance epidemic prevention and control and socio - economic activities.

The role of regular asymptomatic testing in reducing the impact of a COVID-19 wave

Comparison of molecular testing strategies for COVID-19 control: a mathematical modelling study

Role of efficient testing and contact tracing in mitigating the COVID-19 pandemic: a network modelling study

Group Testing for SARS-CoV-2 Allows for Up to 10-Fold Efficiency Increase Across Realistic Scenarios and Testing Strategies

Enhanced testing can substantially improve defence against several types of respiratory virus pandemic

Using random testing to manage a safe exit from the COVID-19 lockdown

Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections

Is "no test is better than a bad test"? Impact of diagnostic uncertainty in mass testing on the spread of COVID-19

Modelling the impact of repeat asymptomatic testing policies for staff on SARS-CoV-2 transmission potential

Quantitative Analysis of the Effectiveness of Antigen- and Polymerase Chain Reaction-Based Combination Strategies for Containing COVID-19 Transmission in a Simulated Community

Optimizing COVID-19 control with asymptomatic surveillance testing in a university environment

Country-specific optimization strategy for testing through contact tracing can help maintain a low reproduction number ([Formula: see text]) during unlock

Testing and Isolation Efficacy: Insights from a Simple Epidemic Model

How could a pooled testing policy have performed in managing the early stages of the COVID‐19 pandemic? Results from a simulation study

Dynamic group testing to control and monitor disease progression in a population

On the Effectiveness of Tracking and Testing in SEIR Models

A Network-Based Model to Explore the Role of Testing in Epidemic Control

The `how' matters: A simulation-based assessment of the potential contributions of LFD tests for school reopening in England

Optimising SARS-CoV-2 pooled testing strategies on social networks for low-resource settings

Cost-effective proactive testing strategies during COVID-19 mass vaccination: A modelling study

On the impact of surveillance test strategies: a cost–benefit modelling analysis based upon real-world data from SARS-CoV-2